Security Snapshot

Kezar Life Sciences, Inc. - Common Stock, $0.001 par value per share (KZR) Institutional Ownership

CUSIP: 49372L209

13F Institutional Holders and Ownership History from Q2 2024 to Q1 2026

Latest Period

Q1 2026

Institutions Reporting

43

Shares (Excl. Options)

4,429,212

Price

$7.42

Save this security page for your next review

Keep this CUSIP in your watchlists so you can revisit quarter changes from one place. If you create an account from here, we will bring you back after verification.

Latest holder snapshot 5 signals
Portfolio coverage rank
0%
Share change
-22,206
Value change
+$578,332
Number of holders
43
Issuer context Names, identifiers, and filing context for this profile. 3 identity fields
Shares outstanding
7,437,095
SEC-reported price per share
$7.29
Insider filing price
$7.29
13F Shares, Excluding Options vs Price
13F Value, Excluding Options
Total Investors

Key facts

  • KZR - Kezar Life Sciences, Inc. - Common Stock, $0.001 par value per share is tracked under CUSIP 49372L209.
  • 43 institutions reported positions in Q1 2026.
  • 1 significant owner is listed from Schedule 13D/13G reporting.

Change

  • Holder count moved from 43 to 43 between Q4 2025 and Q1 2026.
  • SEC-reported value moved from $28,054,562 to $32,846,845.

Research use

  • You can quickly see who holds this security, then open quarter and manager detail pages for full evidence.
  • 13F and Schedule 13D/13G sections are kept together so you can cross-check institutional and beneficial ownership context.

Evidence

Source: SEC Form 13F

Latest holder context comes from 43 institutions filings for Q1 2026.

Open SEC evidence

Security key

49372L209

Latest holder period

Q1 2026

13F holders

43

13D/G owners

1

CIK / CUSIP context first

13D/G owners

Significant owners

Large-stake holder rows connected to Schedule 13D/G evidence.

Rows
1
Security
KZR
Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
Stonepine Capital Management, LLC 2.1% -62% $968,310 -$1,370,578 156,179 -59% Stonepine Capital Management, LLC 31 Dec 2025

As of 31 Mar 2026, 43 institutional investors reported holding 4,429,212 shares of Kezar Life Sciences, Inc. - Common Stock, $0.001 par value per share (KZR). This represents 60% of the company’s total 7,437,095 outstanding shares.

13F concentration

Top 25 institutional shareholders

Largest 13F positions for this security by reported shares and value.

Top holder share
58%
Institution Ownership % Shares Held Share Change % Portfolio % Holdings Value
BML Capital Management, LLC 9.7% 720,787 0% 3.4% $5,348,240
SUVRETTA CAPITAL MANAGEMENT, LLC 9.6% 716,759 0% 0.14% $5,318,352
TANG CAPITAL MANAGEMENT LLC 8.9% 664,314 0% 0.25% $4,929,210
VANGUARD CAPITAL MANAGEMENT LLC 3.9% 290,529 0% 0% $2,155,725
Rangeley Capital, LLC 3.3% 243,073 +183% 2% $1,803,602
Affinity Asset Advisors, LLC 3.1% 229,076 0% 0.1% $1,699,744
RENAISSANCE TECHNOLOGIES LLC 2.5% 188,426 +44% 0% $1,398,121
ACADIAN ASSET MANAGEMENT LLC 2% 151,630 +21% 0% $1,123,000
MILLENNIUM MANAGEMENT LLC 1.9% 142,050 0% $1,054,011
Peapod Lane Capital LLC 1.7% 126,692 -0.01% 0.76% $924,520
Ikarian Capital, LLC 1.4% 102,211 0% 0.11% $758,405
BlackRock, Inc. 1.3% 100,064 +1.4% 0% $742,475
ADAR1 Capital Management, LLC 1.1% 81,933 -30% 0.04% $607,943
Groupe la Francaise 1.1% 80,400 0.01% $596,568
Aldebaran Capital, LLC 1.1% 80,335 -0.37% 0.46% $596,086
GEODE CAPITAL MANAGEMENT, LLC 0.82% 60,988 -11% 0% $452,643
CITADEL ADVISORS LLC 0.8% 59,403 0% $440,770
CREDIT INDUSTRIEL ET COMMERCIAL 0.72% 53,600 0.06% $397,712
TORNO CAPITAL, LLC 0.65% 48,479 +142% 0.15% $359,714
VANGUARD FIDUCIARY TRUST CO 0.55% 41,201 0% 0% $305,711
DIMENSIONAL FUND ADVISORS LP 0.41% 30,334 +14% 0% $225,078
RBF Capital, LLC 0.38% 28,144 0% 0.01% $208,828
STATE STREET CORP 0.36% 27,093 0% 0% $201,030
Yakira Capital Management, Inc. 0.32% 24,000 0.05% $178,080
Vazirani Asset Management LLC 0.3% 22,000 -55% 0.38% $163,240

Quarter history

Institutional holders across reporting periods

Holder count, reported shares/value, and median price by quarter.

Periods
8
Latest
Q1 2026
Rows shown
1-8 of 8
Period 13F Shares, Excl. Options Value, Excl. Options Value Change Price (Median) Investors
2026 Q1 4,429,212 $32,846,845 +$578,332 $7.42 43
2025 Q4 4,460,455 $28,054,562 +$2,498,477 $6.29 43
2025 Q3 4,206,014 $16,401,762 -$1,447,302 $3.90 38
2025 Q2 4,474,800 $20,493,118 +$639,707 $4.58 38
2025 Q1 4,328,239 $21,120,201 +$284,256 $4.88 40
2024 Q4 4,201,005 $28,227,155 +$18,320,837 $6.72 42
2024 Q3 1,440,173 $1,113,903 +$1,099,753 $0.77 3
2024 Q2 18,300 $10,980 +$10,980 $0.60 1
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .